- Home
- SUPN vs PDCO Comparison
SUPN vs PDCO Comparison
Compare SUPN & PDCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- PDCO
- Stock Information
- Founded
- SUPN 2005
- PDCO 1877
- Country
- SUPN United States
- PDCO United States
- Employees
- SUPN N/A
- PDCO N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- PDCO Medical Specialities
- Sector
- SUPN Health Care
- PDCO Health Care
- Exchange
- SUPN Nasdaq
- PDCO Nasdaq
- Market Cap
- SUPN 1.9B
- PDCO 2.7B
- IPO Year
- SUPN 2012
- PDCO 1992
- Fundamental
- Price
- SUPN $36.43
- PDCO $30.82
- Analyst Decision
- SUPN Hold
- PDCO Hold
- Analyst Count
- SUPN 1
- PDCO 7
- Target Price
- SUPN $36.00
- PDCO $27.10
- AVG Volume (30 Days)
- SUPN 348.4K
- PDCO 2.0M
- Earning Date
- SUPN 02-25-2025
- PDCO 02-26-2025
- Dividend Yield
- SUPN N/A
- PDCO 3.37%
- EPS Growth
- SUPN 130.79
- PDCO N/A
- EPS
- SUPN 1.07
- PDCO 1.72
- Revenue
- SUPN $651,972,000.00
- PDCO $6,554,872,000.00
- Revenue This Year
- SUPN $7.82
- PDCO $2.81
- Revenue Next Year
- SUPN N/A
- PDCO $2.87
- P/E Ratio
- SUPN $34.05
- PDCO $17.87
- Revenue Growth
- SUPN 6.79
- PDCO 0.05
- 52 Week Low
- SUPN $25.53
- PDCO $19.45
- 52 Week High
- SUPN $39.37
- PDCO $31.79
- Technical
- Relative Strength Index (RSI)
- SUPN 52.26
- PDCO 83.23
- Support Level
- SUPN $35.73
- PDCO $30.83
- Resistance Level
- SUPN $37.34
- PDCO $30.94
- Average True Range (ATR)
- SUPN 1.20
- PDCO 0.16
- MACD
- SUPN -0.01
- PDCO -0.14
- Stochastic Oscillator
- SUPN 69.02
- PDCO 7.81
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About PDCO Patterson Companies Inc.
Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.